Homocysteine and Hyperhomocysteinaemia.
Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER.
Curr Med Chem. 2019;26(16):2948-2961. doi: 10.2174/0929867325666180313105949.
Homocystinuria: Therapeutic approach.
Kumar T, Sharma GS, Singh LR.
Clin Chim Acta. 2016 Jul 1;458:55-62. doi: 10.1016/j.cca.2016.04.002. Epub 2016 Apr 6.
Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.
Ziegler SG, Kim J, Ehmsen JT, Vernon HJ.
Dis Model Mech. 2023 Nov 1;16(11):dmm050233. doi: 10.1242/dmm.050233. Epub 2023 Nov 23.
Monoamine neurotransmitter deficiencies.
Pearl PL.
Handb Clin Neurol. 2013;113:1819-25. doi: 10.1016/B978-0-444-59565-2.00051-4.
N-homocysteinylation of beta-arrestins biases GPCR signaling and promotes platelet activation.
Zhang LQ, Che CX, Du YQ, Han LL, Wang JL, Zhang CY, Huang SM, Zheng ZY, He QT, Yang Z, Zhang L, Chen N, Yang F, Jia YL, Zhao SM, Zhou DM, Wang C, Wang X, Sun JP, Tie L.
Blood. 2025 May 15;145(20):2374-2389. doi: 10.1182/blood.2024025593.
Hyperhomocysteinaemia.
Perry DJ.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):451-77. doi: 10.1053/beha.1999.0036.
Branched-chain organic acidurias.
Ogier de Baulny H, Saudubray JM.
Semin Neonatol. 2002 Feb;7(1):65-74. doi: 10.1053/siny.2001.0087.
[Inherited hyperammonemia].
Bik-Multanowski M.
Przegl Lek. 1998;55(6):337-41.
[beta-Aminoisobutyricaciduria].
Ohro Y, Wada Y.
Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):241-3.
[Hyperbetaalaninemia].
Kouwaki M, Wada Y.
Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):235-7.
